Michael T. Riebe - Jun 3, 2022 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role
Director
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Michael T. Riebe, Ph.D.
Stock symbol
STSA
Transactions as of
Jun 3, 2022
Transactions value $
$0
Form type
4
Date filed
6/7/2022, 05:34 PM
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STSA Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 3, 2022 Common Stock 30K $3.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in full and become exercisable on the day immediately preceding the 2023 Annual Meeting.